EpitoGenesis acquired preclinical results in murine models demonstrating that the proprietary nutritive immune-enhancing delivery system (NIDS) significantly enhanced immune responses against influenza hemagglutinin and HIV-1 gp120 following mucosal and systemic vaccinations with the same NIDS formulation.
Menu